Ginkgo
Ginkgo biloba
One of the most studied herbs for cognitive function and cerebral blood flow. A living fossil tree whose leaf extract is backed by hundreds of clinical trials for memory and circulation.
What is Ginkgo?
Ginkgo biloba is the sole surviving member of the order Ginkgoales, a 'living fossil' with a lineage dating back 270 million years. Native to China, it is one of the most widely prescribed herbal medicines worldwide, particularly in Europe where standardized leaf extract (EGb 761) is an approved pharmaceutical. The extract has been the subject of over 400 clinical studies examining cognitive function, cerebrovascular health, and neuroprotection.
Known Health Benefits
How It Works
Ginkgo biloba extract (EGb 761) acts through multiple complementary mechanisms. Ginkgolides — particularly ginkgolide B — are potent and selective antagonists of platelet-activating factor (PAF), reducing platelet aggregation and improving microcirculation. Bilobalide protects mitochondrial function and has demonstrated neuroprotective effects against glutamate excitotoxicity. The flavone glycosides (quercetin, kaempferol, isorhamnetin) provide antioxidant protection by scavenging ROS and reactive nitrogen species, particularly in neural tissue. Ginkgo enhances nitric oxide bioavailability, promoting vasodilation in cerebral and peripheral vasculature. It also modulates neurotransmitter systems, increasing serotonin, dopamine, and acetylcholine signaling. These combined vascular and neuronal effects explain its benefits for cognition, memory, and age-related cerebrovascular insufficiency. EGb 761 also inhibits amyloid-β aggregation and tau hyperphosphorylation, mechanisms relevant to Alzheimer's neuropathology.
What Research Says
The landmark GuidAge study (2012), while not showing prevention of Alzheimer's in healthy elderly, demonstrated modest cognitive benefits in a post hoc analysis of compliant participants. Tan et al. (2015) published a meta-analysis of 21 RCTs confirming significant improvement in cognitive function and activities of daily living in dementia patients using EGb 761 at 240 mg/day. A 2010 Cochrane review noted significant benefit for dementia symptoms, though with variable study quality. Ihl et al. (2011) showed significant improvement in neuropsychiatric symptoms and cognitive scores in Alzheimer's and vascular dementia patients. For tinnitus and vertigo, Morgenstern and Biermann (2002) demonstrated significant symptom reduction with EGb 761. The German Institute for Quality and Efficiency in Health Care (IQWiG) accepted ginkgo as beneficial for Alzheimer's-type dementia at 240 mg/day.
Active Compounds
Ginkgolides A/B/C, bilobalide, flavone glycosides
Forms & Bioavailability
The flavone glycosides in EGb 761 achieve ~60% oral bioavailability, with peak plasma levels at 1–3 hours. Ginkgolides have approximately 80% bioavailability. Bilobalide is rapidly absorbed with a plasma half-life of 2–3 hours. Standardized extract (24% flavone glycosides, 6% terpene lactones) ensures consistent pharmacokinetic performance. Food does not significantly affect absorption.
Dosage Guidance
| Use Case | Dosage |
|---|---|
| Cognitive support / dementia | 240 mg EGb 761 daily |
| General brain health | 120–240 mg daily |
| Tinnitus / vertigo | 120–240 mg daily |
| Peripheral circulation | 120–160 mg daily |
Always consult a healthcare provider for personalized dosing.
Potential Side Effects
Headache, GI upset, increased bleeding risk; avoid before surgery
Who Should Avoid It
- Bleeding disorders or concurrent anticoagulant therapy
- Scheduled surgery (discontinue 2 weeks prior)
- Seizure disorders (may lower seizure threshold in some formulations)
- Pregnancy (PAF antagonism may affect implantation)
- Known allergy to ginkgo (contact dermatitis with raw plant; rare with extract)
Pregnancy & Lactation
Contraindicated during pregnancy due to PAF-antagonist effects that may theoretically impair implantation or increase bleeding risk. Insufficient data during lactation. The German Commission E advises against use during pregnancy.
Known Drug Interactions
Interacts with blood thinners, SSRIs, and seizure medications
Evidence Classification
Supported by randomized controlled trials (RCTs), systematic reviews, or meta-analyses published in peer-reviewed journals.
Frequently Asked Questions
How long does ginkgo take to improve memory?
Clinical trials typically show cognitive improvements after 8–12 weeks of consistent use at 240 mg/day. Some studies show earlier benefits (4–6 weeks) in individuals with existing cognitive impairment. Ginkgo is not a quick-acting cognitive enhancer but rather provides gradual neuroprotective and circulatory support.
Can ginkgo prevent Alzheimer's disease?
The GuidAge prevention trial did not conclusively show that ginkgo prevents Alzheimer's in healthy elderly. However, it does improve symptoms in existing dementia (Alzheimer's and vascular types). Current evidence supports ginkgo as a treatment for cognitive decline rather than a preventive measure in healthy individuals.
Is ginkgo safe to take with blood thinners?
Caution is advised. Ginkgo's PAF-antagonist activity has theoretical additive effects with anticoagulants. Case reports of bleeding have occurred with concurrent use. If you are on warfarin, aspirin, or other anticoagulants, consult your prescriber before using ginkgo and monitor INR closely.
What is the difference between ginkgo leaf and ginkgo seeds?
Medicinal ginkgo uses the leaf extract, not the seeds. Ginkgo seeds (eaten in Asian cuisine) contain ginkgotoxin (4'-O-methylpyridoxine), which can cause seizures in large amounts. The standardized leaf extract (EGb 761) has ginkgotoxin removed during processing. Never substitute raw seeds for leaf extract.
Does ginkgo help with tinnitus?
Evidence is mixed but generally positive. Morgenstern and Biermann showed significant improvement in tinnitus symptoms. The benefit is thought to come from improved cochlear blood flow. Results are most likely when tinnitus has a vascular component. A trial of 8–12 weeks at 120–240 mg is reasonable.
References
- Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. Tan MS, Yu JT, Tan CC, et al.. J Alzheimers Dis (2015)View study
- Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomised, placebo-controlled trial. Ihl R, Bachinskaya N, Korczyn AD, et al.. Int J Geriatr Psychiatry (2011)View study
- Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Vellas B, Coley N, Ousset PJ, et al.. Lancet Neurol (2012)View study
- Ginkgo biloba for cognitive impairment and dementia. Birks J, Grimley Evans J. Cochrane Database Syst Rev (2009)View study
Related Health Conditions
Related Supplements
Have questions about Ginkgo?
Ask Mother Nature AI about dosing, interactions with your medications, whether it fits your health goals, and more — personalized to your health profile.
This entry is for educational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement regimen, especially if you take medications or have health conditions.